Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · IEX Real-Time Price · USD
1.530
-0.080 (-4.97%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $3.21M in the twelve months ending March 31, 2024, with 103.46% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $907.64K with 57.92% year-over-year growth. In the fiscal year ending June 30, 2023, Intelligent Bio Solutions had annual revenue of $1.99M with 356.25% growth.
Revenue (ttm)
$3.21M
Revenue Growth
+103.46%
P/S Ratio
1.48
Revenue / Employee
$63,000
Employees
51
Market Cap
4.77M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 1.99M | 1.56M | 356.25% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | 188.56K | 100,295.74% |
| Jun 30, 2019 | 188.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 53.89M |
| Biofrontera | 33.25M |
| Evoke Pharma | 6.11M |
| Exicure | 500.00K |
| Creative Medical Technology Holdings | 9.00K |
INBS News
- 3 days ago - Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success - GlobeNewsWire
- 23 days ago - Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results - GlobeNewsWire
- 24 days ago - Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024 - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions - GlobeNewsWire